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Available online 9 March 2016Ample studies have demonstrated that internet-based cognitive behavioural therapy (iCBT) for anxiety disorders
is effective and acceptable in controlled settings. Studies assessing the clinical effectiveness of iCBT for anxiety
disorders among routine care populations are, however, not as numerous. The purpose of this studywas to assess
the effectiveness of iCBT among anxiety patients, whowere on awaiting list for intensive outpatient treatment, in
a specialised routine care clinic.1
A randomised controlled pilot trial was conducted. Recruited patients were on a waiting list and had a primary
diagnosis of either social phobia or panic disorder. Participants were randomised into either receiving iCBT
with minimal therapist contact (received access to the programme FearFighter® (FF) and received support
from a clinician via telephone) or no treatment (stayed on the waiting list). The primary outcome was self-
reported symptomatic change of anxiety on Beck Anxiety Inventory (BAI). The secondary outcomeswere comor-
bid depression measured on Beck Depression Inventory (BDI-II) and quality of life measured with the EuroQol
one-item visual-analogue scale (EQ-vas). All results were analysed by intention-to-treat analyses using a
mixed-effects approach. N= 158 patients were assessed for eligibility of which N= 67 met all eligibility inclu-
sion criteria, signed informed consent forms, and were randomised. Post-treatment assessment was completed
byN=47 (70%). In the intervention group,N=11 (31%) completed all modules of FF. No signiﬁcant differences
of change of symptomatic levels were found between the intervention and control group for anxiety (BAI: mean
diff. = 2.42; 95% CI−1.03 to 5.86; p=0.17; d=0.06) or for depression (BDI-II: mean diff. 1.87; 95% CI−2.25 to
6.00; p= 0.37; d=0.02). A large and signiﬁcant effect was found in self-reported quality of life in favour of the
experimental group (EQ-vas: mean diff.−20.88; 95% CI−30.64 to−11.11; p b 0.001; d= 0.81).
This study was not able to document statistically signiﬁcant clinical effect of iCBT with minimal therapist contact
compared to a waiting list control group in a specialised anxiety clinic in routine care. However, a large and sig-
niﬁcant effect was seen on self-reported quality of life. Although these results offer an interesting perspective on
iCBT in specialised care, they should be interpretedwith caution, due to the limitations of the study. A large scale
fully powered RCT is recommended.
© 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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Self-help1. Introduction
Panic disorder and social phobia are common, debilitating disorders
characterised respectively by an excessive anxiety response when
experiencing either normal bodily symptoms such as small palpitations).
ty Hospital, DK.
. This is an open access article underorwhen confrontedwith social situations (American Psychiatric Associ-
ation, 2000). A large epidemiological survey estimated a 12-month
prevalence rate of 2.7% for adult panic disorder (with or without agora-
phobia) and 6.8% for adult social phobia (Kessler et al., 2005). Onset is
typically between the ages of 13–15 for social phobia and 24–40 for
panic disorder. If untreated these disorders often become chronic
(Bruce et al., 2005). They are associated with negative consequences
such as impaired career trajectories, absenteeism from work, reduced
work performance, impaired romantic relationships, impaired quality
of life, elevated medical utilisation and high societal costs (Katon,the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Konnopka et al., 2009).
There is now substantial evidence to support internet-based cogni-
tive behavioural therapywithminimal support (iCBT) as being effective
for panic disorder and social phobia compared to non-intervening (Spek
et al., 2007; Barak et al., 2008; Andrews et al., 2010; Andersson et al.,
2014) with large effect sizes (e.g. Carlbring et al., 2006; Berger et al.,
2009).
iCBT even seems to offer treatment results comparable to those of
traditional face-to-face therapy. For example, in a randomised study
by Hedman et al. (Hedman et al., 2011) no difference was found
between iCBT and group face-to-face CBT for social phobia on the
Liebowitz Social Anxiety Scale (non-inferiority randomised design,
where the lower-bound of the 95% CI of the mean difference fell within
10 LSASS points). Similarly, Kiropoulos et al. (Kiropoulos et al., 2008),
found support for iCBT to be equally effective as face-to-face CBT for
panic disorder in a randomised study (post-treatment assessment for
Panic Disorder Severity Scale: iCBT (N = 45): M = 9.92 SD = 5.88;
CBT (N = 35): M = 9.24 SD = 5.65; ANOVA analysis on group effect
p = .88). And in a meta-analysis of studies comparing iCBT with
face-to-face CBT for depression and anxiety disorders, Cuijpers et al.
(Cuijpers et al., 2010) did not ﬁnd support for iCBT to yield smaller
effect sizes than traditional face-to-face CBT.
However, most studies have been conducted under controlled
conditions and have primarily included self-referred patients. To our
knowledge, only a few studies had been conducted on patients in
routine care settings. Cavanagh et al. (Cavanagh et al., 2006) conducted
a naturalistic, open, non-controlled study of adult anxiety and/or de-
pression using the programme Beating the Blues. N= 219was included
of which, N = 84 (38%) dropped out, and N = 104 (47%) completed
post-treatment outcome measures. A signiﬁcant change was found
using intention-to-treat analyses on the Clinical Outcomes in Routine
Evaluation-Outcome Measure (p b 0.001; d = 0.5) and on the Work
and Social Adjustment scale (p b 0.001; d = 0.26). Similarly, in a
specialised CBT clinic Learmonth et al. (Learmonth et al., 2008) conduct-
ed a naturalistic, open, non-controlled study on adult anxiety and/or
depression using theprogrammeBeating theBlues aswell.N=555par-
ticipants were included, and almost three quarters (N = 394≈ 71%)
concluded all modules in the programme. A signiﬁcant improvement
was seen (p b 0.001) on Beck Depression Inventory (d= 0.72) and on
Beck Anxiety Inventory (d = 0.5) using intention-to-treat analyses.
Even though these studies were uncontrolled, a positive effect was indi-
cated for the use of iCBT in routine care.
Since more research on this topic was needed and due to long
waiting lists for anxiety treatment, it was decided to conduct a pilot
RCT on iCBT for these disorders using awaiting list population in an out-
patient clinic for anxiety disorders2 in a Danish specialised care setting.
No studies had been conducted on iCBT in routine care inDenmark up to
this point.
The intervention chosenwas the programme FearFighter® (FF). This
online self-help programme is speciﬁcally designed for panic disorders
and phobias and is completed over 9 steps. Two previous randomised
controlled trials (RCT) had investigated the effectiveness of FF on
adult populations with positive results being indicated. The ﬁrst RCT
was conducted by its original developer Isaac Marks et al. (Marks
et al., 2004) on a population (N = 93) of mainly self-referred patients
who answered notices in general practitioner (GP) ofﬁces or self-help
groups. FF with minimal guidance was compared to face-to-face
therapy and relaxation in a three-arm trial in a 2:2:1 ratio. On the Fear
Questionnaire Global Phobia scale a signiﬁcant difference was found
between FF and relaxation (mean diff. −1.2; 95% CI −2.4 to −0.1;
p b 0.001) but no signiﬁcant difference was found between FF and
face-to-face therapy (mean diff. −0.2; 95% CI −1.2 to 0.8), which2 Clinic for OCD and Anxiety disorders, Aarhus University Hospital, Aarhus, DK.indicated FF to be effective. The secondRCTwas conducted by Schneider
et al. (Schneider et al., 2005) on a population (N=68) referred to a self-
help clinic. This RCT compared FF to a minimal form of iCBT referred to
as ‘anxiety management’ in a 2:1 ratio. Both groups received minimal
guidance in equal doses. In both groups a signiﬁcant improvement
was seen (FF: d=0.5–5.1;MA: d=0.5–5.1; p b 0.01), but no signiﬁcant
between-group effectwas seen (p N 0.3). Therewas, however, a tenden-
cy in favour of FF compared to anxiety management after 14 weeks.
Given the relatively small sample size (N = 68), the active control
condition, and the signiﬁcant within group results in both groups, the
authors conclude that this might also indicate FF to be an effective
treatment.
2. Methods
2.1. Trial design
For the present study, the trial was designed as a pilot two-arm
randomised controlled trial. The experimental group was given access
to FearFighter® (FF) (ST Solutions Ltd., Birmingham, England) with
minimal therapist contact. The control group was placed on a waiting
list for face-to-face CBT as part of normal routine practice and received
no psychological treatment.
2.2. Patients and recruitment
Inclusion criteria were: a primary DSM-IV diagnosis of panic disor-
derwith orwithout agoraphobia or social phobia,mastery of theDanish
language (written and spoken) and access to a computer with a broad-
band Internet connection. Exclusion criteriawere: developmental disor-
ders or other cognitive disabilities or Axis II disorders other than cluster
C (avoidant, dependent, obsessive–compulsive), suicidal plans, bipolar
disorder or depressive psychotic features.
Patients referred to the clinic ﬁrst underwent a diagnostic assess-
ment as part of routine practice to establish diagnosis. They were diag-
nosed by use of (a) the Anxiety Disorders Interview Schedule (Brown
et al., 1994) a reliable, structured interview for anxiety disorders and re-
lated conditions, (b) Structured Clinical Interview for DSM-IV Axis II
Personality Disorders (First et al., 1997) to establish possible axis II dis-
orders, and (c) an anamnestic interview which is a comprehensive in-
terview of the patient and is standard care practice throughout the
Central Region of Denmark. Such an interview includes the patient's so-
cial background and context; history of the disorder e.g. time of onset
and circumstances surrounding that; and other relevant diseases and
disorders e.g. neurological disorders. All interviews were conducted by
trained, experienced clinicians (ﬁve clinical psychologists and one
psychotherapist). After this diagnostic assessment, eligible patients
were asked to participate in the study. Provided that they still wanted
it, the patients were informed that they would still be able to receive
the treatment they were promised even if the iCBT programme helped
them.
Prior to participation all patients signed informed consent docu-
ments; additionally, they received both spoken and written informa-
tion, which explained their rights. The trial was approved by the
Danish Research Ethics Committee (ref. nr. M-20110143).
Within the permitted timeframe of the study (9months for the clin-
ical trial running from September 2011 through July 2012), a total of
N = 158 patients were referred to the clinic. N = 75 patients met the
inclusion criteria and were invited to participate in the study.
2.3. Intervention
In the intervention group, patients used the therapist-assisted, self-
help Internet intervention FearFighter® (FF). FF is an iCBT treatment
and self-management programme for panic disorder and phobic disor-
ders (Marks et al., 2004). It includes weekly screening of symptoms by
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The programme gives feedback to the patient as well as the supporting
clinician about whether symptom levels are constant, rising or falling.
An alarmmessage is given if the patient scores over a pre-set threshold
on a one-item suicidal score. When this occurs, the patient is contacted
for a suicidal assessment interview and referred to an acute ward if
needed. The dose of treatment is nine weekly modules (steps). TheFig. 1.Patientﬂow. BAI: BeckAnxiety Inventory; BDI-II: BeckDepression Inventory II; LSAS-SR: L
— Self Report version; EQ-VAS: EuroQol visual analogue scale.patient can prolong the time intervals between the steps; however, a
time lock prevents the patients from proceeding to the next stepwithin
a shorter time span. The patientswere allowed to use asmuch timewith
the programme as they wished while they were still on the waiting list.
The core clinical elements in the programme are: psycho education,
cognitive restructuring, interoceptive and in vivo exposure exercises,
applied relaxation, restructuring of maladaptive schemas and relapseiebowitz Social Anxiety Scale— Self Report version; PDSS-SR: Panic Disorder Severity Scale
Table 1
Adherence and support.
Mean SD N
Number of telephone calls pr. participant 5.22 1.59 18
Total length of telephone calls in minutes 72.17 38.64 18
Length of telephone calls pr. participant 55.9 32.2 18
Number of steps completed in the FearFighter programme 5.28 3.27 36
Number of days spend with the programme 123 59.94 36
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range of multimedia channels, including audio/video of a therapist,
case and exercise demonstration, text on screen as slides next to the
therapist in the videos, printout summaries, exercise descriptions and
material for non-professional helpers, automated email reminders,
graphics and animations (Kenwright et al., 2004). The programme
was translated to Danish. Small cultural adaptations were made to ﬁt
the Danish context of the study. These adaptations included videos
and pictures, which were taken in locations familiar to the Danish pop-
ulation. Additionally, Interoceptive exposure was added and included:
hyperventilation, spinning on an ofﬁce chair and running on the spot.
Unique usernames and passwords were used to protect the par-
ticipants' privacy, and all saved data were securely transferred and
encrypted.
By use of 10-minute telephone calls, all participants in the interven-
tion group received synchronous support weekly or biweekly from
either a clinical psychologist or a psychotherapist trained in CBT.
The calls were initiated by the clinicians and were prescheduled. The
support included technical assistance and problem solving regarding
any difﬁculties or lack of progress with the therapy. Participants were
also encouraged to continue the treatment.
The participants were advised to ask a friend or a familymember for
support through the programme. Information about the role of a helper,
which the patient could provide the helper with, was given to the
patient as a downloadable pdf ﬁle.
The support staff consisted of the same experienced CBT clinicians
(ﬁve clinical psychologists and one psychotherapist) whowere respon-
sible for the intake. They all went through a one-day training course
which included instructions in using the clinician side of the pro-
gramme and training in providing support to the participants in the for-
mat of 10 min telephone calls as required for the present study. As
preparation for the training, they had all gone through the FearFighter®
programme.
Patients in the control condition received no psychological treatment.
2.4. Outcome measures
2.4.1. Primary outcome measure
The BeckAnxiety Inventory (BAI) is a 21-item self-report instrument
for assessing the severity of anxiety in psychiatric patients (Beck et al.,
1988a). It has a high internal consistency with a Cronbach's alpha of
0.92 and test retest reliability of r = 0.75 (Beck et al., 1988a).
2.4.2. Secondary outcome measures
The BeckDepression Inventory (BDI-II) is a 21-item self-reportmea-
sure used to determine the presence and severity of depressive symp-
toms (Beck et al., 1988b). Internal consistency of the original BDI is
excellent with a Cronbach's alpha of 0.86, and test–retest reliability is
also high (Beck et al., 1988b). In the present study the BDI-II, which
has been shown to have similar properties, is used (Beck et al., 1996).
The Panic Disorder Severity Scale (PDSS) is a seven-item scale that
was used to assess symptoms of panic disorder (Houck et al., 2002). It
has been found to have excellent inter-rater reliability on all scale
items ranging from r = 0.74 to 0.87, moderate internal consistency
with Cronbach's alpha of 0.65 and favourable levels of validity and
sensitivity to change (Shear et al., 1997). In the present study the self-
report version was used.
The Liebowitz Social Anxiety Scale (LSAS) is comprised of 24 social
situations that are each rated for level of fear over the past week
(Liebowitz, 1987). In the present study it was used in the self-report
format. LSAS has shown a high test–retest reliability over 12 weeks
with an r = 0.83 (Fresco et al., 2001). LSAS-SR has a high internal
consistency with a Cronbach's alpha = 0.95 (Baker et al., 2002).
Finally, patients scored their health-related quality of life on the
EuroQol visual analogue scale (EQ-vas) (EuroQol Group, 1990). This is
a one-item visual-analogue scale on which the patient scores his orher subjective experience of general state of health on a continuous
line with scores ranging from 0 to 100.
2.5. Sample size
Previous studies of FF (Marks et al., 2004) have found medium to
large effect sizes between FF and control conditions. Following Cohen
(Cohen, 1992), to detect a medium difference between two indepen-
dent sample means (d = .50) at alpha = .05 and power of .80 requires
N = 64 in each group.
2.6. Randomisation
Randomisationwas performed using a computer-generated string of
100 binary random numbers (www.random.org) placed sequentially in
concealed envelopes. A secretary not involved in the study administered
the randomisation.
2.7. Statistical analyses
We used descriptive statistics to compare the intervention group
with controls on various baseline characteristics. This allowed us to
check for the presence of confounding variables. We used a two-sided
student's t-test for the comparison of variables of continuous nature,
such as age, while for the categorical variables we used a chi-squared
test of proportions. In addition to this, we compared the intervention
group with controls on outcome measures at baseline as well as
follow-up using a two-sided student's t-test. Furthermore, we reported
the mean and standard deviation of duration and number of telephone
calls as well as number of steps completed in the FearFighter® pro-
gramme for the intervention group.
The analyses of change conducted were intention-to-treat (ITT) lin-
ear regression using a mixed effects approach with a random intersec-
tion at subject level. We used all observations available for these
analyses. Since difference of change over time between intervention
group and controls was the main interest of the analysis, an interaction
term was added to the model. Standardised effect sizes in the form of
Cohen's d were calculated for all mean differences of change between
intervention group and controls.
All outcome measures were checked for normality by visual inspec-
tion of the quantile-normal plots.
A p-value lower than 0.05 was considered statistically signiﬁcant.
The statistical package STATA version 13 was used for all analyses.
3. Results
3.1. Inclusion
As can be seen in Fig. 1, 158 patients were referred to the clinic
during the study period. 75 patients met all inclusion criteria for the
study and were invited to participate. 8 were excluded because they
either declined to participate (N = 4) or contact was lost (N = 4).
Thus, a total of 67 patientswere randomisedwhereof 36were randomly
allocated to the intervention group and 31 to the control group.
Table 2
Baseline characteristics.
Intervention
group
Control group p-Value
Gender (N, %)
Female 23 63.89 18 60.00
Male 13 36.11 12 40.00 0.7457
Age at baseline (mean, SD) 32.39 12.30 29.23 8.81 0.2441
Psychotropic drugs (N, %)
Yes 26 72.22 18 60.00
No 10 27.78 12 40.00 0.2943
Primary diagnosis (N, %)
PD 12 33.33 7 23.33
SP 24 66.67 23 76.67 0.3716
Comorbid Affective (N, %)
Yes 21 58.33 8 26.67
No 15 41.67 22 73.33 0.0099
BDI II 14–19 5 41.67 8 61.11
BDI II 20–28 10 13.89 7 22.22
BDI II 29–63 13 27.78 6 19.44 0.2390
Comorbid Personality (N, %)
Yes 9 25.00 8 26.67
No 27 75.00 22 73.33 0.8775
Employed/student (N, %)
Yes 14 38.89 15 50.00
No 22 61.11 15 50.00 0.3651
Alcohol consumption per week (N, %)
Never drink 12 33.33 8 26.67
0–5 23 63.89 15 50.00
5–10 0 0.00 4 13.33
10–20 1 2.78 3 10.00 0.0720
PD: panic disorder; SP: social phobia.
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All 36 participants assigned to the intervention group completed
baseline measurements and 22 (61%) completed post-treatment mea-
surements. Only 11 (31%) out of the 36 allocated participants concluded
the programme in its entirety whereof 1 did not submit post-treatment
data. 14 (39%) counted as dropped out of the study either because they
began other treatment (N=8) or they never started (N=6). Of the 31
participants allocated to the control group, 30 (97%) completed baseline
measurements and 25 (81%) completed the post-measurements.
Participants in the control group were rated after four months
(122 days), whereas a wide variation was seen in the days spent
with the programme in the intervention group (m = 123 days,
sd = 59.94).
Support was provided as short prescheduled telephone calls initiat-
ed by the clinicians. AmeanofM=10.7minwas spent per call.3 Amean
ofM= 55.9 min (SD = 32.2; range: [20–149]) was spent per patient.
Results of duration of support calls could only be obtained from 18 par-
ticipants (50%)most likely caused by forgetfulness of the therapists due
to the stressed reality of clinical practice(Table 1).
3.3. Baseline characteristics
Baseline characteristics for both groups are seen in Table 2. There
were no statistically signiﬁcant differences between the two groups
on any measure at baseline except for depression. In the experimental
condition a higher number of participants (N = 21) were diagnosed
with a comorbid depressive disorder when compared to the control
group (N = 8), based on the clinical assessment interview (p b 0.01).
For this reasonwe controlled for comorbid affective disorder in all anal-
yses. Furthermore, when the participants were split into degrees of se-
verity based on BDI-II scores, more than twice the number of patients3 The standard deviation of time spent on individual phone calls could not be calculated,
as only the sum of minutes spent on each patient was available to the research team.scored over the cut-off for severe depression (BDI-II score ≥ 30) in the
intervention group. However, there was no statistically signiﬁcant dif-
ference in the distribution of degrees of depression severity between
the two groups (p= 0.24).
3.4. Outcome
The observed means and standard deviations of the outcome mea-
sures at baseline as well as follow-up for both the intervention group
and the controls are shown in Table 3. The mean differences of out-
comes between the two groups at both time points are likewise
shown in Table 3. No statistically signiﬁcant differences between the
groups were found as has been showed in Table 3.
As can be seen in Table 4, the results of the intention-to-treat linear
regression analysis (ITT) on the primary measure of symptoms of
anxiety (BAI) reported no statistically signiﬁcant difference of change
between the groups (mean diff. = 2.42; 95% CI −1.03 to 5.86; p =
0.17; d= 0.06).
Likewise, we found no statistically signiﬁcant difference of change
on the secondary outcomemeasure of symptomatic levels of depression
(BDI-II) when comparing the intervention group to the control group
(mean diff. 1.87; 95% CI −2.25 to 6.00; p = 0.37; d = 0.02). There
was, however, a small statistically signiﬁcant favourable within-group
change in the intervention group on the BDI-II (mean diff. −3.70;
p = 0.02) but not in the control group (mean diff.−1.53; p = 0.28).
A large and statistically signiﬁcant between-group beneﬁcial difference
of changewas seen on the EQ-vas (mean diff.−20.88; 95% CI−30.64 to
−11.11; p b 0.001; d= 0.81).
4. Discussion and conclusion
The present pilot study examinedwhether it was feasible to conduct
an iCBT trial in routine practice in Denmark andwhether it was an effec-
tive treatment for social phobia and panic disorder when delivered to
patients on a waiting list for CBT treatment in comparison to a non-
intervening control condition in routine care in a specialised anxiety
clinic. The programme FearFighter® was used since it had, in previous
RCT's, been shown to be an effective treatment for these disorders
(Marks et al., 2004).
Results show that we were able to recruit patients from the waiting
list (N = 67). We did, however, not ﬁnd a signiﬁcant difference of
change in favour of the experimental group on symptomatic levels of
neither anxiety (BAI: mean diff. = 2.42; 95% CI −1.03 to 5.86; p =
0.17; d = 0.06) nor depression (BDI-II: mean diff. 1.87; 95% CI−2.25
to 6.00; p= 0.37; d= 0.02).
These results resembles those of a recent study by Kok et al. (Kok
et al., 2014) in which a different, but functionally equivalent iCBT inter-
vention was investigated in an RCT recruiting from specialised anxiety
clinics in routine care in the Netherlands. They did ﬁnd a signiﬁcant,
though small, effect (N=210; d=0.35; p=0.02) on the primary out-
comemeasure of symptomatic levels of phobia using the Fear Question-
naire. Nonetheless, no signiﬁcant difference between the groups was
found on the secondary measure of BAI (p = 0.5). Given the fact that
the previous studies of FF used the Fear Questionnaire, which could
seem to be more sensitive to change, this may shed some light on the
presumably different results between the present and the previous
RCT's of FF.
Also, the previous RCT's on FF were conducted on patient groups
with less severe comorbidity. In the study from 2004, Marks et al. com-
pared FF with clinician-guided self-exposure and applied relaxation. In
the population studied (N = 90), few had comorbid psychiatric disor-
ders (7%) compared with the present study (affective disorders FF =
58%, Control = 27%; personality disorders FF = 25%, Control = 27%).
In the study from 2005, Schneider, Mataix-Cols et al. demonstrated sig-
niﬁcant treatment effect in a self-help clinic. Therewas no clear descrip-
tion of baseline characteristics and the presence of comorbid disorders
Table 3
Observed means of outcome measures.
Mean intervention group (SD) Mean control group (SD) Mean difference 95% CI p-Value N intervention N control
Observed mean of outcome measures at baseline
BAI 22.86 (10.41) 22.23 (8.54) 0.63 −4.12 5.37 0.7923 36 30
BDI-II 22.72 (10.66) 20.17 (10.68) 2.56 −2.71 7.82 0.3361 36 30
EQ-vas 49.26 (19.14) 49.18 (19.64) 0.09 −9.80 9.97 0.9862 34 28
Observed mean of outcome measures at follow-up
BAI 16.00 (10.12) 19.68 (9.56) −3.68 −9.47 2.11 0.2067 22 25
BDI-II 17.36 (11.77) 18.68 (9.87) −1.32 −7.67 5.04 0.6787 22 25
EQ-vas 63.52 (19.10) 45.04 (20.83) 18.48 6.40 30.56 0.0035 21 24
BAI: Beck Anxiety Inventory; BDI-II: Beck Depression Inventory II; EQ-VAS: EuroQol visual analogue scale.
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sembled those adopted in the present study, severe depression was ex-
cluded. By comparison 28% (N= 19) of the participants in the present
study reported severe depression at baseline. This was particularly
true in the intervention group whereof 36% reported severe depression
at baseline (n = 13). From these observations it could be speculated
that high degrees of comorbidity and, perhaps particularly, severe de-
pression might reduce the clinical effectiveness of iCBT when delivered
in a formatwithminimal therapist contact as it has been indicated to be
the case in some studies (Chambless et al., 1997; Collimore and Rector,
2012).
The results did show a large and statistically signiﬁcant beneﬁcial
effect on the self-reported quality of life (EQ-vas). Though this may
seem contradictory to the apparent lack of treatment effect, it may
be due to the participants appreciating being able to do something
themselves to change their situations and that the programme in-
duced hope and a sense of control. It can also be speculated that re-
ceiving information about their conditions enabled the patients to
distance themselves from their illnesses. All of these explanations were
indicated by participant comments during the supporting telephone
calls.
This was a pilot trial with a number of limitations. It is possible that
the explanation for the lack of treatment effect lies in the study's lack of
power. Our power calculations stated that 64 participants were needed
in each group, while wewere only able to recruitN=67 in total during
the pre-speciﬁed time period of the study. However, in addition to high
p-values, the results also showed very low standardised effect sizes for
most of the scores. This could indicate that the statistically insigniﬁcant
results were due to more than low power. Moreover, some of the esti-
mated effects are likely explained by the phenomena “regression to
the mean”. Another explanation for the statistically insigniﬁcant effect
of the clinical outcome measures may be due to the fact that only 11
participants actually completed all nine steps in the FearFighter® pro-
gramme. A completers analysis may give more insight to whether this
was the case; however, such an analysis in the current study would be
greatly underpowered. Furthermore, the participants in the control
group were rated after precisely four months (122 days), whereas a
wide variation was seen in the days spent with the programme in the
intervention group (m= 123 days, sd = 59.94). Additionally, the par-
ticipants were referred to the clinic with the promise of face-to-faceTable 4
Linear regression analyses of between-group change over time.
Change intervention group p-Value Change control group p-Value M
BAI −5.293 0.0000 −2.873 0.0217 2
BDI-II −3.504 0.0247 −1.533 0.2788 1
EQ-vas 16.276 0.0000 −4.391 0.2076 −
BAI: Beck Anxiety Inventory; BDI-II: Beck Depression Inventory II; EQ-VAS: EuroQol visual anatreatment and it was clear from interviews conducted after the treat-
ment, that many patients did not regard the iCBT as the “real” interven-
tion but rather as a sort of training or preparation for “the real
treatment”. This was in spite of the fact that the patients were told oth-
erwise. This might have compromised the patients expectancy of treat-
ment effect of the iCBT and damaged the working alliance which might
have compromised treatment outcome (Waller and Gilbody, 2009;
Ritterband et al., 2010; Preschl et al., 2011). Finally, the EQ-VAS is a
one-item measurement scale. The use of one item scales have been
criticised for being scientiﬁcally weak because of poor reliability, valid-
ity, and responsiveness due to the scales' lack of a general reference
frame. For this reason, each respondent may answer the question
from a different frame of reference and thus render the underlying con-
structmeasured toowide. Consequently, the answers can be ambiguous
(Hobart et al., 2007). However, there is evidence to support that there is
a satisfactory correlation between the EQ5D-5L index score and the EQ-
VAS score (Konig et al., 2010; Feng et al., 2014).
In conclusion,wewere able to conduct a study on iCBT and to recruit
patients from the waiting list of a specialised care clinic. The interven-
tion did even seem to improve the participants' quality of life signiﬁ-
cantly. However, no statistically signiﬁcant difference in symptomatic
change of anxiety or depression was seen from pre to post treatment
measurements between the intervention group and the control group.
These results should, though, be interpreted with great caution due to
the limitations of the study.
Further research is needed to explore this topic. AnRCT conducted in
routine care with sufﬁcient power to detect a small effect size would be
recommended. Also, a study of iCBT in a blended care format in
specialised care would be recommended.
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from all involved in the project.ean diff. of change over time 95% CI p-Value Std. effect size
.415 −1.033 5.863 0.1699 0.06
.873 −2.253 5.998 0.3737 0.02
20.876 −30.644 −11.107 0.0000 0.81
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